Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company has one operating segment with a focus on the development of novel drug therapies, including cancer therapies, extending new applications of radiation therapy, and other drug development, including through the use of the Molecule.ai platform by the company as well as licensing the right to use Molecuile.ai to others. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. Its pipeline includes: Ropidoxuridine, HDAC Inhibitors, PSMA-B, and PC-Rad Test.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$11.7M
- Total assets
- $10.5M
- Market cap
- $2.7M
- Operating margin
- 125.2%
- Net margin
- 123.2%
Source: SEC EDGAR · updated Jun 8, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- -$9.5M
- Operating expenses
- $11.9M
- Operating income
- -$11.9M
- Net income
- -$11.7M
- EPS (basic)
- $-7.16
- EPS (diluted)
- $-7.16
Balance sheet
- Total assets
- $10.5M
- Current assets
- $502.9K
- Total liabilities
- $8.2M
- Current liabilities
- $8.0M
- Shareholders’ equity
- $2.3M
Cash flow
- Operating cash flow
- -$9.5M
- Investing cash flow
- -$3.1M
- Financing cash flow
- $11.0M
- Net cash flow
- -$1.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $2.7M
- EPS (diluted)
- $-7.16
- Shares outstanding
- 919.2K
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 31, 2022
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price
- Reported a net loss of $11.7M.
- Trading 94% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Shuttle Pharmaceuticals Holdings, Inc..
Write a review
News about Shuttle Pharmaceuticals Holdings, Inc.
News & sentiment via Polygon.io
Shuttle Pharmaceuticals Holdings, Inc.: frequently asked questions
Is Shuttle Pharmaceuticals Holdings, Inc. an American company?
Shuttle Pharmaceuticals Holdings, Inc. is a US-based company headquartered in Gaithersburg, Maryland, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Shuttle Pharmaceuticals Holdings, Inc. headquartered?
Shuttle Pharmaceuticals Holdings, Inc. is headquartered in Gaithersburg, Maryland, United States.
Is Shuttle Pharmaceuticals Holdings, Inc. publicly traded?
Yes — Shuttle Pharmaceuticals Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol SHPH on the NASDAQ.
What does Shuttle Pharmaceuticals Holdings, Inc. do?
Shuttle Pharmaceuticals Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
